The Lymphoma Research Foundation’s free webinars are hour-long interactive programs led by leading lymphoma experts who discuss lymphoma, treatment options, clinical trials, and promising innovative research. Webinars can be listened to live on the telephone or via web streaming.
Treating Lymphoma with Bispecific Antibodies
DATE: Tuesday, November 19, 2024
TIME: 12:00 PM – 1:00 PM Eastern Time
VIRTUAL PROGRAM – This is a Zoom virtual event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio. Note: Look for Zoom as sender of confirmation and reminder emails.
Featuring
Jennifer Crombie, MD
Hematologist/Oncologist
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School
Manali Kamdar, MD
Hematologist/Oncologist
Associate Professor, Medicine – Hematology
Clinical Director of Lymphoma Services
University of Colorado
Program Overview
- Overview and Understanding Bispecific Antibody Therapy
- When to Consider Bispecific Antibody Therapy as a Treatment Option for Lymphoma
- Looking Forward: Update on Clinical Trials for Bispecific Antibody Therapies
- Managing Potential Treatment Side Effects and the Role of the Care Partner
- Questions and Answers Session
Ways to Register
VIRTUAL PROGRAM – This is a Zoom virtual event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio. Note: Zoom will send a confirmation and reminder email.
Call: 800-500-9976
Email: helpline@lymphoma.org
This program is for patients and survivors, caregivers and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email vgonzalez@lymphoma.org to learn more about sponsorship.
Disclaimer: The Lymphoma Research Foundation is a national nonprofit organization based in the United States with educational programs and resources are intended for a US-based audience. These program and resources address available lymphoma treatments in the United States. and information on drug approvals by the US Food and Drug Administration.
For individuals outside of the US, we recommend the Lymphoma Coalition at www.lymphomacoalition.org. The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non US-based audiences.
Program Supporters
This program is supported through unrestricted educational grants from: